ACE2 and COVID-19: The locations of angiotensin-converting enzyme 2 in the eye are the conjunctiva, cornea, and retina.[1,2] Cases of conjunctival infection with COVID-19 are the most frequently reported, with an incidence rate of 0.8% to 32%.[3–6] COVID-19-induced viral keratitis has also been occasionally found.[7,8] Although the SARS-CoV-2 virus has been found in the vitreous and retina of COVID-19 deceased patients,[9,10] posterior segment damage, especially retinal disease, caused by COVID-19 infection is still relatively rare.